HPV16 E6-antibody associated risk of oropharyngeal cancer increases by calendar-time: A nested case-control study

Affiliations

• ¹ Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
• ² Division of Infections and Cancer Epidemiology, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
• ³ Finnish Cancer Center Mid, Tampere, Finland.
• ⁴ Finnish Cancer Registry, Helsinki, Finland.
• ⁵ Finnish Maternity Cohort, University of Oulu, Oulu, Finland.
• ⁶ European Scientific Infra-structure Services (ESIS), Oulu, Finland.
• ⁷ Department of Otorhinolaryngology - Head and Neck Surgery, Research Program in Systems Oncology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
• ⁸ Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.